Voting for two students to receive two scholarships — valued at $22,000 each — is now open to the public…
Articles by Marisa Wexler, MS
The investigational therapy MS1819 showed positive safety results in a Phase 2 clinical trial for the treatment of…
A new agreement will give people in Scotland with cystic fibrosis access to the CF combination treatments Orkambi…
How well Acceptance and Commitment Therapy (ACT), or tailored “talk” therapy that can be delivered via telemedicine, helps people with…
Claire’s Place Foundation is preparing for its 5th Annual Glow Ride event to raise money to support families affected…
The presence of the fungus Aspergillus fumigatus is linked to lower respiratory-related quality of life in people with cystic…
Path BioAnalytics (PBA), a biotechnology company based in North Carolina, has licensed the rights to further develop cavosonstat (N91115), a targeted…
A 10th anniversary screening of the documentary “65_RedRoses” will take place on Sunday, Sept. 8, at the Vancouver Playhouse Theatre…
The first patient has been dosed in a Phase 2 clinical trial testing Proteostasis Therapeutics‘s combinations of three investigational…
Vertex Pharmaceuticals is asking the U.S. Food and Drug Administration to approve a first triple combination therapy —  elexacaftor…